History

2020
Established Jiangsu Putai Pharmaceutical Technology Co., Ltd. (wholly-owned subsidiary of ProteLight Pharmaceutical's health care products) .
Established Wuxi Ruiyi Pharmaceutical Co., Ltd. (wholly-owned sales subsidiary of Putai Pharmaceutical) . Established Wuxi Ruiyi Pharmaceutical Co., Ltd. (wholly-owned sales subsidiary of Putai Pharmaceutical) .
Established Wuxi Ruiyi Pharmaceutical Co., Ltd. (wholly-owned sales subsidiary of Putai Pharmaceutical) . Established Wuxi Ruiyi Pharmaceutical Co., Ltd. (wholly-owned sales subsidiary of Putai Pharmaceutical) .

2019
The new industrial base officially opened.

2017
The construction of a new industrial base began.

2015
The sales of antimicrobial peptides and other disinfection and sterilization products with multiple barcodes were launched.

2014
The Wenning series was awarded a Chinese invention patent.

2013
The production of various disinfection and sterilization products was launched.

2012
The manufacturing license of the world's first antibacterial peptide (Flowtide) antibacterial lotion was obtained.

2011
Settled into the Jiangyin Yangtze River Biomedical Accelerator. The 1800 ㎡ purification production plant for disinfection and sterilization products was completed.

2009
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. was officially established and settled in the Jiangyin Baiqiao International Biotechnology Incubation Park. (Parent company of Putai Pharmaceuticals)
